Two years after Genta Inc.’s Chapter 7 bankruptcy liquidation, the Securities and Exchange Commission charged the biopharmaceutical company’s former president and chief medical officer Loretta Itri and two others with insider trading.
In an April 21 complaint, the SEC alleged that Itri told a longtime friend about the negative results...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?